Aug 4, 2026 6:30am EDT Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026
Jul 30, 2026 6:30am EDT Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries